Literature DB >> 10933656

Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS.

M Ruhnke1, A Schmidt-Westhausen, J Morschhäuser.   

Abstract

In this report, we describe a patient with recurrent episodes of oral candidosis who finally suffered from fluconazole-refractory oral and oesophageal candidosis. The patient was monitored for 4 years until his death from AIDS. During the observation period, persistent colonization with both Candida albicans and Candida dubliniensis was observed. From the appearance of the first episode of oral candidosis, the patient was treated with fluconazole for 18 months. The infection became unresponsive to fluconazole 400 mg/day. In vitro susceptibility testing revealed the development of resistance to fluconazole in C. albicans and C. dubliniensis. Molecular typing confirmed the persistence of the same C. albicans and C. dubliniensis strains which developed resistance after up to 3 years of asymptomatic colonization. This observation demonstrates that Candida spp. other than C. albicans may develop resistance to fluconazole in a patient who is repeatedly exposed to the drug.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933656     DOI: 10.1093/jac/46.2.291

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  22 in total

1.  Transcriptional profiling of azole-resistant Candida parapsilosis strains.

Authors:  A P Silva; I M Miranda; A Guida; J Synnott; R Rocha; R Silva; A Amorim; C Pina-Vaz; G Butler; A G Rodrigues
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.

Authors:  Sabrina Schubert; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

3.  Rapid identification and differentiation of Candida albicans and Candida dubliniensis by capillary-based amplification and fluorescent probe hybridization.

Authors:  Rangaraj Selvarangan; Ajit P Limaye; Brad T Cookson
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  The Efficacy and Safety of Miconazole Nitrate Mucoadhesive Tablets versus Itraconazole Capsules in the Treatment of Oral Candidiasis: An Open-Label, Randomized, Multicenter Trial.

Authors:  Zhimin Yan; Xiaosong Liu; Yang Liu; Ying Han; Mei Lin; Wenmei Wang; Xiaobing Guan; Shengrong Zhu; Handong Zhang; Qintao Wang; Lihong Chou; Xinghao Zhu; Hong Hua
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

5.  Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression.

Authors:  Emmanuelle Pinjon; Colin J Jackson; Steven L Kelly; Dominique Sanglard; Gary Moran; David C Coleman; Derek J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

6.  First reported case of endocarditis caused by Candida dubliniensis.

Authors:  Michael J Carr; Susan Clarke; Finbar O'Connell; Derek J Sullivan; David C Coleman; Brian O'Connell
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

7.  Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.

Authors:  Marcos Martinez; José L López-Ribot; William R Kirkpatrick; Brent J Coco; Stefano P Bachmann; Thomas F Patterson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  The effect of gentian violet on virulent properties of Candida albicans.

Authors:  Su Ying; Sun Qing; Li Chunyang
Journal:  Mycopathologia       Date:  2009-11-24       Impact factor: 2.574

Review 9.  Third case of Candida dubliniensis endogenous endophthalmitis in North America: case report and review of the literature.

Authors:  Elizabeth Rosenberger; Dima A Youssef; Sara Safdar; Cristoforo R Larzo; James Myers
Journal:  Int Ophthalmol       Date:  2014-08       Impact factor: 2.031

10.  Molecular mechanisms of itraconazole resistance in Candida dubliniensis.

Authors:  Emmanuelle Pinjon; Gary P Moran; Colin J Jackson; Steven L Kelly; Dominique Sanglard; David C Coleman; Derek J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.